- Home
- NBXG vs ABCL Comparison
NBXG vs ABCL Comparison
Compare NBXG & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBXG
- ABCL
- Stock Information
- Founded
- NBXG 2021
- ABCL 2012
- Country
- NBXG United States
- ABCL Canada
- Employees
- NBXG N/A
- ABCL N/A
- Industry
- NBXG Trusts Except Educational Religious and Charitable
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- NBXG Finance
- ABCL Health Care
- Exchange
- NBXG Nasdaq
- ABCL Nasdaq
- Market Cap
- NBXG 900.2M
- ABCL 772.9M
- IPO Year
- NBXG N/A
- ABCL 2020
- Fundamental
- Price
- NBXG $12.60
- ABCL $2.03
- Analyst Decision
- NBXG
- ABCL Buy
- Analyst Count
- NBXG 0
- ABCL 3
- Target Price
- NBXG N/A
- ABCL $7.50
- AVG Volume (30 Days)
- NBXG 243.7K
- ABCL 4.1M
- Earning Date
- NBXG 01-01-0001
- ABCL 05-08-2025
- Dividend Yield
- NBXG 10.25%
- ABCL N/A
- EPS Growth
- NBXG N/A
- ABCL N/A
- EPS
- NBXG N/A
- ABCL N/A
- Revenue
- NBXG N/A
- ABCL $23,114,000.00
- Revenue This Year
- NBXG N/A
- ABCL N/A
- Revenue Next Year
- NBXG N/A
- ABCL $36.62
- P/E Ratio
- NBXG N/A
- ABCL N/A
- Revenue Growth
- NBXG N/A
- ABCL N/A
- 52 Week Low
- NBXG $9.31
- ABCL $1.89
- 52 Week High
- NBXG $12.23
- ABCL $4.34
- Technical
- Relative Strength Index (RSI)
- NBXG 59.71
- ABCL 34.87
- Support Level
- NBXG $12.38
- ABCL $1.98
- Resistance Level
- NBXG $12.77
- ABCL $2.64
- Average True Range (ATR)
- NBXG 0.23
- ABCL 0.14
- MACD
- NBXG 0.11
- ABCL -0.06
- Stochastic Oscillator
- NBXG 88.72
- ABCL 7.14
About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in "NextGen Companies".
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.